First published online March 30, 2004
doi: 10.1242/10.1242/dev.01054
Development 131, 1703-1715 (2004)
Published by The Company of Biologists 2004
Inhibition of the cell cycle is required for convergent extension of the paraxial mesoderm during Xenopus neurulation
Walter F. Leise, III1,* and
Paul R. Mueller2,
1 Department of Biochemistry and Molecular Biology, University of Chicago, 924
East 57th Street, Chicago, IL 60637, USA
2 Department of Molecular Genetics and Cell Biology, Center for Molecular
Oncology, and Committees on Developmental Biology, Cancer Biology, and
Genetics, University of Chicago, 924 East 57th Street, Chicago, IL 60637,
USA

View larger version (65K):
[in a new window]
|
Fig. 2. The low mitotic index of the paraxial mesoderm requires Wee2. (A) Wee2
targeted morpholinos (W2MO.1 and W2MO.2), but not a control morpholino (CMO)
or water (No MO), blocked the in vitro translation of a mRNA containing the
5'UTR of Wee2 fused to GFP. (B) W2MO.1 and W2MO.2, but not CMO, reduce
the endogenous levels of the Wee2 protein. 40 ng of CMO, W2MO.2 or W2MO.1 were
microinjected into each cell of two-cell embryos. Sibling is a non-injected
control. At stage 18, these embryos were analyzed for Wee2 and Myt1 protein
levels by western analysis. (C) W2MO.1 reduces the level of endogenous Wee2
protein in a dose-dependent manner. 40 ng CMO; or 10, 20 or 40 ng W2MO.1 were
microinjected into each cell of two-cell embryos and then processed as in B.
The total amount of morpholino injected is indicated. (D) Embryos were
microinjected as in B with CMO (odd panels) or W2MO.1 (even panels), and
allowed to develop to stage 18. Panels 1 and 2 are composite images of eight
serial sagittal sections from representative embryos that were processed for
PH3 staining. Note the increase in mitotic cells (black dots) within the
paraxial mesoderm of Wee2-depleted embryos (panel 2). Panels 3 and 4 are
sagittal sections of embryos processed for MyoD in situ analysis. These same
MyoD sections were subsequently stained with SYTOX Green to visualize the
nuclei (panels 5 and 6). Nuclei in the paraxial mesoderm appear dimmer owing
to the MyoD staining. Note the absence of somites in Wee2-depleted embryos.
Labels and orientation as in Fig.
1A. (E) Depletion of Wee2 protein causes cell proliferation within
the paraxial mesoderm but not the axial mesoderm. The total number of nuclei
within the paraxial and axial mesoderm was determined by counting all nuclei
within the MyoD-(paraxial mesoderm, PM) or XNot-(axial mesoderm, AM) positive
regions of representative embryos that were microinjected with either CMO or
W2MO.1. Every section of both transversely (MyoD and XNot) and sagittally
(MyoD) cut embryos was counted and totaled. Data are -fold change from the
control (CMO=1). (F) The total volume of MyoD-expressing tissue does not
change with depletion of Wee2 protein. The same transverse and sagittal MyoD
stained sections used in E were used to determine the area of MyoD expression.
Data are -fold change from the control (CMO=1).
|
|

View larger version (78K):
[in a new window]
|
Fig. 3. Wee2 is required for anterior-posterior embryo elongation, somite
formation, and convergent extension. (A) Wee2-depleted embryos fail to extend
along the anteroposterior axis and fail to form somites. Embryos were treated
as in Fig. 2D, but allowed to
develop until the controls reached stage 25 before being processed for MyoD in
situ analysis. Anterior towards the right, dorsal towards the top. Labels as
in Fig. 1A. Scale bar: 300
µm. (B) Unilateral depletion of Wee2. One blastomere (asterisk) of a
two-cell embryos was microinjected with 40 ng CMO or W2MO.1. These were
allowed to develop until controls reached stage 19 and photographed. Dorsal
view, anterior towards the top. Note curvature and reduced somitic ridge
(arrow) on the Wee2-depleted side. (C) Mesoderm specific gene expression is
unchanged in Wee2-depleted embryos. Quantitative RT-PCR for MyoD, XNot, Vent1,
MA, MHC and ornithine decarboxylase (ODC) from whole, stage 18 embryos treated
with W2MO.1, CMO or nothing (Sibling). (D) Depletion of Wee2 compromises
convergent extension driven elongation of dorsal explants. Embryos were
treated with W2MO.1 or CMO as in Fig.
2D and then processed for dorsal explants. Explants were
photographed when controls reached stage 26. Scale bar: 1 mm.
|
|

View larger version (100K):
[in a new window]
|
Fig. 4. Depletion of Wee2 protein disrupts convergent extension of the paraxial
mesoderm during neurulation. (A-C,F) Temporal analysis of Wee2-depleted
embryos during neurulation. Embryos were microinjected as in
Fig. 2D with CMO (odd panels)
or W2MO.1 (even panels), and were allowed to develop until controls reached
the indicated stages before being processed for MyoD (A), XNot (B), MA and MHC
(C), or Sox3 (F) in situ analysis as indicated. Green arrows indicate a closed
blastopore. Lateral limits of paraxial mesoderm (MyoD expression) are
indicated by broken red lines. White and yellow arrows indicate lack of
anterior neural fold and somitic ridge, respectively. Lateral limits of
presumptive neural tissue (Sox3 expression) are indicated by red arrows and
vertical lines. (D) The paraxial mesoderm of Wee2-depleted embryos fails to
converge towards the midline. Representative CMO and W2MO.1 treated, MyoD
stained, stage 18 embryos from 4A were serially sectioned transversely. The
anteroposterior positions of the shown sections are indicated by letters in
right lower corner of panels as per E. Dorsal is towards the top. Black arrow
indicates the forming somitic ridge. (E) Drawing reproduced, with permission,
from Nieuwkoop and Faber (Nieuwkoop and
Faber, 1994 ) showing position of cuts in D.
|
|

View larger version (136K):
[in a new window]
|
Fig. 5. Rescue of Wee2-depleted embryos. Both blastomeres of two-cell embryos were
microinjected with a combination of 40 ng W2MO.1 and either injection buffer
(panels 1-4), 20 pg Wee2 mRNA (panels 5-8) or 40 pg Wee2 (panels 9-12). These
were allowed to develop until non-injected siblings (panels 13-16) reached
stage 19. Subsequently, the embryos were subjected to MyoD or Sox3 in situ
analysis as indicated. Lateral limits of paraxial mesoderm (MyoD expression)
are indicated by broken red lines. Lateral limits of presumptive neural tissue
(Sox3 expression) are indicated by red arrows and vertical lines.
|
|

View larger version (77K):
[in a new window]
|
Fig. 6. Expression of constitutively active Cdk2 phenocopies the convergent
extension defects observed in Wee2-depleted embryos. (A) Both blastomeres of
two-cell embryos were microinjected with 230 pg of Cdk2WT or Cdk2AF mRNA as
indicated. These embryos were allowed to develop until stage 18 before being
processed for MyoD or XNot in situ analysis. Lateral limits of paraxial
mesoderm (MyoD expression) are noted by broken lines. Arrow indicates lack of
anterior neural fold. (B) The paraxial mesoderm of Cdk2 AF-treated embryos
fails to converge towards the midline. Representative Cdk2WT or Cdk2AF
treated, MyoD stained, stage 18 embryos from 6A were serially sectioned
transversely. The anteroposterior positions of the shown sections are
indicated by letters in right lower corner of panels as per
Fig. 4E. Dorsal towards the
top. Black arrow denotes the forming somitic ridge. (C) Expression of Cdk2AF
causes cell proliferation within the paraxial mesoderm but not the axial
mesoderm. The total number of nuclei within the paraxial and axial mesoderm of
representative embryos from 6A was determined as in
Fig. 2E. (D) Cdk2 AF treatment
compromises convergent extension driven elongation of dorsal explants. Embryos
were injected with Cdk2 WT or Cdk2 AF mRNA as in A and then processed for
dorsal explants. Explants were photographed when controls reached stage 24.
Scale bar: 1 mm. (E) Mesoderm specific gene expression is unchanged in Cdk2
AF-treated embryos. Quantitative RT-PCR for MyoD, XNot, Vent1, MA, MHC and ODC
from whole, stage 18 embryos injected as in A with Cdk2 AF mRNA, Cdk2 WT mRNA,
or nothing (Sibling).
|
|

View larger version (106K):
[in a new window]
|
Fig. 7. Paraxial mesoderm targeted expression of wild-type Cdc25 disrupts
convergent extension. (A) Dorsal and posterior views of embryos unilaterally
injected with 100 pg of the indicated Cdc25 plasmid DNA. Embryos were allowed
to develop until stage 19 before being processed for GFP in situ analysis.
Cells expressing GFP-Cdc25 stain blue. WT [wild type (active)] and PD
[phosphatase-dead (inactive)] forms of Cdc25A or Cdc25C. Lateral limits of
GFP-Cdc25 positive cells are indicated by broken lines. Arrows indicate the
lack of a somatic ridge. (B) Dorsal, anterior and sectioned views of embryos
unilaterally injected and treated as in A, except 300 pg of Cdc25A plasmid DNA
was used. Arrow indicates somitic ridge.
|
|
© The Company of Biologists Ltd 2004